1. Jazz Pharmaceuticals (NASDAQ:JAZZ)
Jazz Pharmaceuticals (NASDAQ:JAZZ) is one of the best cheap biotech stocks to buy now. Jazz Pharmaceuticals (NASDAQ:JAZZ) was initiated with an Overweight rating by Barclays on February 27, with the firm setting a $224 price target on the shares and stating that its key opinion leader calls show that the company’s central nervous system base business is “sticky.” It also sees “oncology-fueled” Ziihera growth in multiple tumor types in the longer term, with significant readouts in 2027 for the company.
Jazz Pharmaceuticals (NASDAQ:JAZZ) received several other bullish rating updates on February 25. Morgan Stanley lifted the price target on the stock to $226 from $225 and maintained an Overweight rating on the shares, updating estimates on the stock following the release of its fiscal Q4 report. The same day, Deutsche Bank also lifted the price target on Jazz Pharmaceuticals (NASDAQ:JAZZ) to $255 from $210 and reiterated a Buy rating on the shares.
Jazz Pharmaceuticals (NASDAQ:JAZZ) also received a bullish rating update from BofA on February 25. The firm reiterated a Buy rating on the shares and raised the price target to $275 from $263, telling investors that while the fiscal Q4 results included modest top and bottom-line beats, FY26 revenue guidance was about in-line with the firm’s forecast and 3% below consensus at the mid-point. The firm further noted that “solid” guidance should allow investors to own the stock for Ziihera’s gastroesophageal adenocarcinoma launch.
Jazz Pharmaceuticals (NASDAQ:JAZZ) develops medicines for serious diseases. Its primary marketed products include Xywav, Xyrem oral solution, Epidiolex oral solution, Rylaze, Zepzelca, Defitelio, and Vyxeos liposome for injection. These medicines treat excess daytime sleepiness (EDS) in narcolepsy patients seven years of age or older, tepatic veno-occlusive disease (VOD), and other ailments.
While we acknowledge the potential of JAZZ to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than JAZZ and that has 100x upside potential, check out our report about this cheapest AI stock.
READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
